Ardea Biosciences, Inc. (RDEA) Posts Q2 Loss of 68c, Wider than Views
Tweet
Share
E-mailGet Alerts RDEA Hot Sheet
Join SI Premium – FREE
Ardea Biosciences, Inc. (NASDAQ: RDEA) reported Q2 loss of ($0.68), $0.16 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.69 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
